-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Clinical Discussant for Myelofibrosis

Program: Special-Interest Sessions
Session: ASH-FDA Joint Symposium I: Targeted, Gene and Cellular Therapy - Recent Approvals in Non-Malignant Hematology
Monday, December 11, 2023, 10:30 AM-12:00 PM

Jeanne Palmer, MD

Mayo Clinic - Arizona, Scottsdale, AZ

Disclosures: Palmer: CTI BioPharma Corp.: Consultancy, Honoraria, Other: Money went to institution; Sierra Oncology: Consultancy, Other: Money went to Institution; morphosys: Consultancy, Other: Money went to institution; Jubliant: Consultancy; Incyte: Consultancy, Other: Money went to the institution.

See more of: ASH-FDA Joint Symposium I: Targeted, Gene and Cellular Therapy - Recent Approvals in Non-Malignant Hematology
See more of: Special-Interest Sessions
<< Previous Presentation | Next Presentation >>